Nouscom secures 67.5 million euros in financing Biotech company Nouscom has raised 67.5 million euros in a series C financing round. The…martin11.14.2023
Celebrating six months of innovation: i4Challenge accelerator New Ideas 2022/2023 On the 5th of July 2023, the 3rd iteration of the i4Challenge accelerator program New…lenka11.14.2023
Paradigm shift in pain management Pain is a crucial sensation for survival, but it can also drive us to depression…martin11.10.2023
Investors stump up 3.7 million Swiss francs in Onena Medicines Onena Medicines has secured an investment of 3.7 million Swiss francs. The portfolio company of…martin11.03.2023
CSL joins Basel Area biotech cluster The research and development department of the globally active Australian biotech company CSL has moved…martin11.02.2023
Palto Therapeutics receives 150,000 Swiss francs from Venture Kick Allschwil-based Palto Therapeutics has won the third stage of the Venture Kick promotional funding program.…martin10.30.2023
Roche uses artificial intelligence for cancer diagnosis Roche is teaming up with Ibex Medical Analytics and Amazon Web Services in the field…martin10.26.2023
Cimeio collaborating with the University of Pennsylvania The Basel-based startup Cimeio has been offered an exceptional opportunity for a preclinical research collaboration…martin10.17.2023
i4Challenge 2023: 11 winning projects push the boundaries of innovation With the i4Challenge program running for the sixth time, 6 “Innovative Solutions” and 5 “New…lenka10.05.2023
Opportunities in the Metaverse In our 12th iteration of the Technology Circle (21.06.2023), we learned from four speakers what…clement10.04.2023